Welcome to our dedicated page for Photronics SEC filings (Ticker: PLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Photronics Inc filings document an operating semiconductor-supply-chain company whose common stock trades on the Nasdaq Global Select Market under PLAB. The company's regulatory record includes current reports on quarterly results, financial-condition exhibits, executive officer appointments, board changes, and compensation arrangements.
Proxy and annual-meeting filings cover director elections, auditor ratification, shareholder voting results, board composition, executive compensation, and governance procedures. These disclosures sit alongside the company's public-company capital structure, including common stock with $0.01 par value per share.
Mary Paladino, a director of Photronics, Inc. (PLAB), reported the sale of 42,750 shares of common stock on 10/02/2025 at a price of $24 per share. After the transaction, she is reported to beneficially own 33,798 shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025.
Photronics (PLAB) insider filing reports a proposed sale of 10,000 common shares that were acquired through restricted stock vesting on 01/03/2025. The shares carry an aggregate market value of $253,307.50 and the approximate sale date is 10/06/2025 on NASDAQ. The filing states the shares were issued as compensation and fully paid on 01/03/2025. The filing also discloses a prior sale by Frank K. Lee of 8,750 shares on 08/29/2025 for gross proceeds of $203,031.56. The signer certifies no undisclosed material adverse information is known.
Eric Rivera, who is listed as EVP, CFO of Photronics Inc. (PLAB), reported a non-derivative disposition of 1,959 shares of common stock on 10/01/2025. The filing states the shares were withheld to meet tax liabilities associated with Restricted Stock Awards granted on 10/01/2024. After the reported withholding, Mr. Rivera beneficially owned 119,815 shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The transaction is reported as a routine tax-withholding related to equity compensation rather than an open-market sale.
Form 144 filed for Photronics, Inc. (PLAB) reports a proposed sale of 42,750 common shares with an aggregate market value of $1,026,000 via Fidelity Brokerage Services, expected on or about 10/02/2025. The filing states there are 59,004,625 shares outstanding, so the proposed sale represents a small fraction of the company.
The 42,750 shares were acquired through restricted stock vesting between January 2020 and April 2023 in scheduled tranches and were issued as compensation. The filer certifies they do not possess undisclosed material adverse information.
Photronics, Inc. (PLAB) filed its Form 10-Q for the quarter ended August 3, 2025, presenting condensed consolidated interim financial statements and MD&A. The company reported cash and cash equivalents of $479.5 million, down from $598.5 million at October 31, 2024, with $416.1 million held by foreign subsidiaries (including $328.2 million in joint ventures). Photronics repurchased 5.0 million shares for $97.4 million year-to-date and completed an additional 1.2 million shares for $20.7 million in the quarter; $27.6 million remains available under its repurchase authorization.
The company expects fiscal 2025 capital expenditures of about $200 million, had outstanding capital commitments of $147.2 million, and estimates funding of approximately $154.8 million of committed obligations over the next twelve months. Photronics consolidated results include its China joint venture (PDMCX) and reported decreased net income attributable to noncontrolling interests versus prior periods. Key risks and exposures disclosed include a $69.7 million pre-tax potential loss from a 10% adverse foreign currency move and ongoing evaluation of recent U.S. tax law changes.
Park Han Kyung, Senior Vice President & General Manager of FPD Ops at Photronics Inc. (PLAB), reported a sale of 15,000 shares of common stock on 09/03/2025 at a price of $22 per share. Following the reported transaction, the filing shows 103,000 shares beneficially owned directly. The Form 4 discloses the insider disposition and the remaining direct holdings.
Christopher J. Progler, EVP and Chief Technology Officer of Photronics Inc. (PLAB), reported the sale of 10,000 shares of the issuer's common stock on 09/02/2025 at a weighted average price of $21.93 per share. After the sale, Mr. Progler beneficially owns 200,591 shares. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on December 22, 2024, and prices on the multiple trades ranged from $21.77 to $22.12. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Lee Kang Jyh, a director of Photronics Inc (PLAB), reported the sale of 8,750 shares of the company's common stock on 08/29/2025 in multiple transactions at prices ranging from $23.20 to $23.23. After these disposals, the reporting person beneficially owns 523,350 shares, reported as direct ownership. The Form 4 indicates the trades were executed across several transactions and that the reporting person will provide detailed per-transaction counts and prices on request. The form was submitted by an attorney-in-fact on behalf of the reporting person.
Photronics, Inc. (PLAB) Form 144 notice: A holder intends to sell 15,000 shares of common stock through Fidelity Brokerage Services on or about 09/03/2025, with an aggregate market value of $330,000. The issuer reports 60,150,512 shares outstanding. All 15,000 shares were acquired in early January 2025 through restricted stock vesting as compensation (5,000 on 01/02/2025 and 10,000 on 01/03/2025). No securities by this person were sold in the past three months. The filer certifies no undisclosed material adverse information is known.
Form 144 filed for Photronics, Inc. (PLAB) discloses a proposed sale of 10,000 common shares through Fidelity Brokerage Services, with an aggregate market value listed at $219,326.89 and an approximate sale date of 09/02/2025 on NASDAQ. The filing shows the 10,000 shares were originally acquired through restricted stock vesting on 01/03/2023 (6,022 shares) and 01/02/2024 (3,978 shares) as compensation. The filer previously sold 10,000 shares on 07/28/2025 for gross proceeds of $210,716.70. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and includes signature and attestation language required by Rule 144.